Bengt Mannervik

Oxford Biomedical

Oxford Biomedical Gets $1.2M Grant To Develop Proteomic Toxicity Screening Panel

Oxford Biomedical Research Inc., a privately held biotechnology company in Rochester Hills, has been awarded a $1,163,600 Phase 2 Small Business Innovation Research Grant by the National Institute of Environmental Health Sciences.

WWJ Newsradio 950–12/09/2013

Follow

Get every new post delivered to your Inbox.

Join 2,343 other followers